NR565 | NR565 Advanced Pharmacology
Fundamentals Exam 1 v2 | Questions with Correct
Answers and Expert Explanation for Each Question
| Chamberlain
1. A patient is taking a drug that has a narrow therapeutic index. Which action by the
nurse practitioner is most important to ensure patient safety?
A. Instruct the patient to take the medication on an empty stomach.
B. Monitor plasma drug levels regularly to avoid toxicity.
C. Advise the patient to increase fluid intake significantly.
D. Switch the patient to a generic version of the drug immediately.
Correct Answer: B
Expert Explanation: A narrow therapeutic index means there is a small margin
between the effective dose and the toxic dose. Monitoring plasma drug levels is
crucial to ensure the concentration stays within the safe range. This prevents
adverse effects while maintaining therapeutic efficacy in the patient.
2. Which process of pharmacokinetics is primarily affected by a patient’s liver
function?
A. Absorption
B. Distribution
,C. Metabolism
D. Excretion
Correct Answer: C
Expert Explanation: Metabolism, also known as biotransformation, occurs
primarily in the liver via the cytochrome P450 system. Impaired liver function can
lead to decreased drug breakdown and potential toxicity. Therefore, assessing
hepatic enzymes is a standard practice before prescribing many medications.
3. A drug that mimics the action of a natural ligand at a receptor site is classified as
a(n):
A. Antagonist
B. Partial Agonist
C. Competitive Inhibitor
D. Agonist
Correct Answer: D
Expert Explanation: An agonist is a molecule that activates receptors by mimicking
the body’s own regulatory molecules. This binding triggers a biological response
that is similar to the endogenous substance. In contrast, antagonists work by
blocking the receptor from being activated.
,4. What is the primary factor that determines the rate of drug absorption when
administered orally?
A. The patient’s age and weight
B. The drug’s half-life in the bloodstream
C. The solubility and surface area available for absorption
D. The protein-binding capacity of the drug
Correct Answer: C
Expert Explanation: Oral drug absorption is heavily dependent on the drug’s lipid
solubility and the surface area of the small intestine. High lipid solubility allows the
drug to pass through cell membranes more easily. A larger surface area increases
the total amount of drug that can enter the circulation at once.
5. A patient with chronic kidney disease (CKD) requires a medication that is primarily
excreted renally. What adjustment should the NP anticipate?
A. Increasing the dose to ensure efficacy
B. Administering the drug via the IV route only
C. Reducing the dose or increasing the dosing interval
D. No adjustment is necessary for renal excretion
Correct Answer: C
, Expert Explanation: In patients with renal impairment, the clearance of drugs
excreted by the kidneys is reduced. Failure to adjust the dose can lead to drug
accumulation and significant toxicity. The NP must use the creatinine clearance or
GFR to determine the appropriate dosage reduction.
6. Which of the following describes the ‘first-pass effect’?
A. The rapid excretion of a drug by the kidneys
B. The metabolism of a drug in the liver before it reaches systemic circulation
C. The initial distribution of a drug to the brain
D. The binding of a drug to plasma albumin
Correct Answer: B
Expert Explanation: The first-pass effect occurs when an oral drug is absorbed
from the GI tract and carried directly to the liver via the portal vein. If the liver
metabolizes the drug extensively, only a small fraction of the active dose reaches the
systemic circulation. This is why some drugs must be given parenterally or in much
higher oral doses.
7. An NP prescribes an inducer of the CYP3A4 enzyme for a patient already taking a
drug metabolized by the same enzyme. What is the likely result?
A. Decreased plasma levels of the original drug
B. Increased plasma levels of the original drug
Fundamentals Exam 1 v2 | Questions with Correct
Answers and Expert Explanation for Each Question
| Chamberlain
1. A patient is taking a drug that has a narrow therapeutic index. Which action by the
nurse practitioner is most important to ensure patient safety?
A. Instruct the patient to take the medication on an empty stomach.
B. Monitor plasma drug levels regularly to avoid toxicity.
C. Advise the patient to increase fluid intake significantly.
D. Switch the patient to a generic version of the drug immediately.
Correct Answer: B
Expert Explanation: A narrow therapeutic index means there is a small margin
between the effective dose and the toxic dose. Monitoring plasma drug levels is
crucial to ensure the concentration stays within the safe range. This prevents
adverse effects while maintaining therapeutic efficacy in the patient.
2. Which process of pharmacokinetics is primarily affected by a patient’s liver
function?
A. Absorption
B. Distribution
,C. Metabolism
D. Excretion
Correct Answer: C
Expert Explanation: Metabolism, also known as biotransformation, occurs
primarily in the liver via the cytochrome P450 system. Impaired liver function can
lead to decreased drug breakdown and potential toxicity. Therefore, assessing
hepatic enzymes is a standard practice before prescribing many medications.
3. A drug that mimics the action of a natural ligand at a receptor site is classified as
a(n):
A. Antagonist
B. Partial Agonist
C. Competitive Inhibitor
D. Agonist
Correct Answer: D
Expert Explanation: An agonist is a molecule that activates receptors by mimicking
the body’s own regulatory molecules. This binding triggers a biological response
that is similar to the endogenous substance. In contrast, antagonists work by
blocking the receptor from being activated.
,4. What is the primary factor that determines the rate of drug absorption when
administered orally?
A. The patient’s age and weight
B. The drug’s half-life in the bloodstream
C. The solubility and surface area available for absorption
D. The protein-binding capacity of the drug
Correct Answer: C
Expert Explanation: Oral drug absorption is heavily dependent on the drug’s lipid
solubility and the surface area of the small intestine. High lipid solubility allows the
drug to pass through cell membranes more easily. A larger surface area increases
the total amount of drug that can enter the circulation at once.
5. A patient with chronic kidney disease (CKD) requires a medication that is primarily
excreted renally. What adjustment should the NP anticipate?
A. Increasing the dose to ensure efficacy
B. Administering the drug via the IV route only
C. Reducing the dose or increasing the dosing interval
D. No adjustment is necessary for renal excretion
Correct Answer: C
, Expert Explanation: In patients with renal impairment, the clearance of drugs
excreted by the kidneys is reduced. Failure to adjust the dose can lead to drug
accumulation and significant toxicity. The NP must use the creatinine clearance or
GFR to determine the appropriate dosage reduction.
6. Which of the following describes the ‘first-pass effect’?
A. The rapid excretion of a drug by the kidneys
B. The metabolism of a drug in the liver before it reaches systemic circulation
C. The initial distribution of a drug to the brain
D. The binding of a drug to plasma albumin
Correct Answer: B
Expert Explanation: The first-pass effect occurs when an oral drug is absorbed
from the GI tract and carried directly to the liver via the portal vein. If the liver
metabolizes the drug extensively, only a small fraction of the active dose reaches the
systemic circulation. This is why some drugs must be given parenterally or in much
higher oral doses.
7. An NP prescribes an inducer of the CYP3A4 enzyme for a patient already taking a
drug metabolized by the same enzyme. What is the likely result?
A. Decreased plasma levels of the original drug
B. Increased plasma levels of the original drug
